RESEARCH-USE BIOSIMILAR ANTIBODY
Nivolumab
Monoclonal antibody · IgG4
Nivolumab is a programmed death receptor-1 (PD-1) blocking human IgG4 antibody to treat advanced (metastatic) non-small cell lung cancer.
TARGETPDCD1
YMonoclonal antibody
CATALOGSC-BS-333
CATALOG NUMBERSC-BS-333
MOLECULAR WEIGHTApprox. 143.62 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Nivolumab is a programmed death receptor-1 (PD-1) blocking human IgG4 antibody to treat advanced (metastatic) non-small cell lung cancer.
Nivolumab is a recombinant research-use antibody directed against PDCD1.